According to a newly published market research report by 24LifeSciences, global heart valves tester market was valued at USD 287.4 million in 2024 and is projected to reach USD 463.8 million by 2032, growing at a compound annual growth rate (CAGR) of 6.1% during the forecast period 2025–2032.

Heart valves testers are specialized medical devices designed to evaluate the performance and durability of both transcatheter and surgical heart valves under simulated physiological conditions. These advanced testing systems assess critical parameters such as flow rates, pressure differentials, cyclic loading, and leakage prevention across aortic, mitral, pulmonary, and tricuspid valve replacements. They play an essential role in ensuring patient safety and regulatory compliance while facilitating innovation in cardiovascular medical device development.